Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mannkind Corp (NQ: MNKD )

4.730 +0.030 (+0.64%)
Streaming Delayed Price Updated: 2:57 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Mannkind Corp

< Previous 1 2 3 4 Next >
MannKind (MNKD) Q1 2024 Earnings Call Transcript
MNKD earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
MNKD Stock Earnings: MannKind Beats EPS, Beats Revenue for Q1 2024
MNKD stock results show that MannKind beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
MannKind Earnings Preview
Via Benzinga
A Preview Of MannKind's Earnings
Via Benzinga
Why MannKind Stock Soared 19% Higher on Tuesday
The biotech delivered quite an impressive earnings report. 
Via The Motley Fool
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday. 
Via Benzinga
Topics Stocks
Exposures US Equities
What's Going On With MannKind Stock?
MannKind Corporation shares are trending on social media Monday. CNBC's Jim Cramer mentioned the stock on the "Mad Money Lightning Round" Friday. The stock has been "hanging out there forever, and it's... 
Via Benzinga
Cramer Says Sprout Social Is In A 'Hot Spot,' But This Energy Stock Is 'Too Down And Out'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he needs to do more work on Sprout Social, Inc. (NASDAQ: SPT) as it is in a "hot spot, but the stock is not making money. And because the... 
Via Benzinga
MannKind (MNKD) Q4 2023 Earnings Call Transcript
MNKD earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
MannKind (MNKD) Q2 2023 Earnings Call Transcript
MNKD earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Earnings Preview For MannKind
Via Benzinga
3 Biotech Stocks to Sell in January Before They Crash and Burn
The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell. 
Via InvestorPlace
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Longboard Pharmaceuticals, Inc. 
Via Benzinga
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results. 
Via Benzinga
High-Yield Haven: 3 Dividend Stocks to Secure Now
These are three different dividend stocks that have a great dividend yield and offer a reliable source of income. 
Via InvestorPlace
MannKind (MNKD) Q3 2023 Earnings Call Transcript
MNKD earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
MannKind Analyst Turns Bullish, Says 'Don't Call It Comeback'
Shares of MannKind Corp (NASDAQ: MNKD) were climbing in early trading on Tuesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Via Benzinga
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners. 
Via InvestorPlace
3 Biotech Stocks to Sell in August Before They Crash and Burn
These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late. 
Via InvestorPlace
Intuit To Rally More Than 20%? Here Are 10 Other Analyst Forecasts For Monday
Keybanc lowered the price target for Bumble Inc. (NASDAQ: BMBL) from $25 to $24. Keybanc analyst Justin Patterson maintained an Overweight rating. Bumble shares rose 0.9% to $16.65 in pre-market... 
Via Benzinga
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
These three worst biotech stocks are not investable even if you're bullish on the sector overall. There are better options. 
Via InvestorPlace
7 Biotech Stocks to Sell in July
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July. 
Via InvestorPlace
7 Overvalued Penny Stocks to Sell Before June 2023
It's time to make your exit from these overvalued penny stocks to sell, as their respective valuations are unsustainable. 
Via InvestorPlace
3 Biotech Stocks to Avoid Like the Plague
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs. 
Via InvestorPlace
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.